Status:
COMPLETED
Scan-rescan Reproducibility of Myelin Sensitive MRI Techniques
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Myelin Integrity
Eligibility:
All Genders
18-80 years
Brief Summary
This study is to assess the variation in the measurements of myelin sensitive MRI techniques in both white and grey matter in the brain.
Detailed Description
Magnetization Transfer Imaging (MTI) permits the assessment of the integrity of macromolecules in brain tissue, such as myelin and cellular/axonal membrane components. Multi-echo Susceptibility-Based...
Eligibility Criteria
Inclusion
- No neurological or psychiatric disorder
Exclusion
- Pregnancy
- Contraindication to MRI (eg, claustrophobia, metallic implants, pacemaker etc).
- Inability to give consent.
Key Trial Info
Start Date :
February 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04673734
Start Date
February 5 2021
End Date
September 30 2021
Last Update
December 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurologische Klinik und Poliklinik, University Hospital Basel
Basel, Switzerland, 4031